SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-071153
Filing Date
2014-11-26
Accepted
2014-11-26 14:30:24
Documents
1
Group Members
EMERALD CAPITAL CORP.PINETREE CAPITAL INVESTMENT CORP.PINETREE INCOME PARTNERSHIPSHELDON INWENTASH

Document Format Files

Seq Description Document Type Size
1 SC 13G v395385_sc13g.htm SC 13G 103601
  Complete submission text file 0001144204-14-071153.txt   105579
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.) (Subject) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49893 | Film No.: 141253118
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 130 KING STREET W. SUITE 2500 TORONTO A6 M5X 1A9
Business Address 130 KING STREET W. SUITE 2500 TORONTO A6 M5X 1A9 416-941-9600
Pinetree Capital Ltd. (Filed by) CIK: 0001314173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G